Kwang Dong Pharmaceutical Co., Ltd. (KRX:009290)
South Korea
· Delayed Price · Currency is KRW 5,710.00
-70.00 (-1.21%)
Feb 21, 2025, 9:00 AM KST
Kwang Dong Pharmaceutical Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Feb '25 Feb 20, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Market Capitalization | 224,292 | 297,799 | 244,840 | 305,229 | 421,076 | 263,211 | Upgrade
|
| Market Cap Growth | -2.18% | 21.63% | -19.78% | -27.51% | 59.98% | -5.31% | Upgrade
|
| Enterprise Value | 341,390 | 283,794 | 196,173 | 300,829 | 390,078 | 300,684 | Upgrade
|
| Last Close Price | 5710.00 | 7430.00 | 5879.78 | 7209.84 | 9813.83 | 6303.29 | Upgrade
|
| PE Ratio | 6.76 | 8.06 | 10.13 | 12.71 | 9.28 | 11.42 | Upgrade
|
| Forward PE | - | 14.32 | 14.32 | 14.32 | 14.32 | 14.32 | Upgrade
|
| PS Ratio | 0.14 | 0.20 | 0.17 | 0.23 | 0.34 | 0.21 | Upgrade
|
| PB Ratio | 0.40 | 0.51 | 0.45 | 0.58 | 0.84 | 0.59 | Upgrade
|
| P/TBV Ratio | 0.44 | 0.59 | 0.49 | 0.63 | 0.90 | 0.65 | Upgrade
|
| P/FCF Ratio | - | - | 6.54 | 9.80 | 23.97 | 15.81 | Upgrade
|
| P/OCF Ratio | - | - | 3.90 | 5.56 | 18.45 | 8.99 | Upgrade
|
| EV/Sales Ratio | 0.21 | 0.19 | 0.14 | 0.22 | 0.31 | 0.24 | Upgrade
|
| EV/EBITDA Ratio | 8.60 | 5.16 | 3.75 | 5.09 | 5.88 | 4.96 | Upgrade
|
| EV/EBIT Ratio | 13.07 | 6.75 | 5.13 | 6.69 | 8.37 | 7.19 | Upgrade
|
| EV/FCF Ratio | -4.49 | - | 5.24 | 9.66 | 22.21 | 18.06 | Upgrade
|
| Debt / Equity Ratio | 0.47 | 0.40 | 0.25 | 0.25 | 0.22 | 0.25 | Upgrade
|
| Debt / EBITDA Ratio | 7.26 | 4.29 | 2.64 | 2.24 | 1.65 | 1.85 | Upgrade
|
| Debt / FCF Ratio | - | - | 3.69 | 4.24 | 6.25 | 6.74 | Upgrade
|
| Asset Turnover | 1.49 | 1.51 | 1.58 | 1.56 | 1.53 | 1.62 | Upgrade
|
| Inventory Turnover | 6.78 | 6.95 | 7.34 | 6.58 | 6.21 | 7.51 | Upgrade
|
| Quick Ratio | 0.97 | 1.03 | 1.23 | 1.32 | 1.24 | 1.13 | Upgrade
|
| Current Ratio | 1.41 | 1.46 | 1.71 | 1.81 | 1.93 | 1.63 | Upgrade
|
| Return on Equity (ROE) | 5.91% | 6.94% | 4.97% | 4.96% | 9.60% | 5.16% | Upgrade
|
| Return on Assets (ROA) | 1.52% | 2.62% | 2.63% | 3.28% | 3.59% | 3.43% | Upgrade
|
| Return on Capital (ROIC) | 2.00% | 3.49% | 3.56% | 4.42% | 4.97% | 4.78% | Upgrade
|
| Return on Capital Employed (ROCE) | 3.97% | 6.77% | 6.61% | 8.05% | 8.82% | 8.63% | Upgrade
|
| Earnings Yield | 15.10% | 12.41% | 9.87% | 7.87% | 10.77% | 8.76% | Upgrade
|
| FCF Yield | -33.90% | -15.62% | 15.29% | 10.20% | 4.17% | 6.32% | Upgrade
|
| Dividend Yield | 1.75% | 1.35% | 1.70% | 1.39% | 1.02% | 1.27% | Upgrade
|
| Payout Ratio | 11.83% | 11.11% | 16.99% | 17.10% | 6.98% | 13.94% | Upgrade
|
| Buyback Yield / Dilution | 1.58% | 1.48% | 0.11% | -1.48% | -2.24% | 2.29% | Upgrade
|
| Total Shareholder Return | 3.33% | 2.83% | 1.82% | -0.09% | -1.22% | 3.56% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.